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A Bridge Too Far? 





The Economic Value Added (EVA
™
) framework has engendered a great deal of attention from 
American and European companies, consultants, accounting firms, security analysts, fund 
managers and the media for its purported utility in accurately valuing public companies.  In 1996, 
for example, Fortune Magazine trumpeted that hundreds of companies had recently “renounced” 
earnings per share in favour of EVA
™
 as a means of measuring performance and driving stock 
prices.  During the 1990s, investors witnessed unprecedented growth in US equity prices, 
particularly for technology firms.  This case study critically examines the Economic Value Added 
EVA
™
 framework and attempts to rationalize the bull market in technology stocks by employing 
EVA
™
 to estimate the intrinsic value of a large proportion of the US technology sector as of 1999 
and comparing this figure with contemporaneous market values for the same.  We find a marked 
disparity between EVA
™
 estimates of Present Value and actual market value for the sector. 
 





etween January 1990 and March of 2000, the technology-laden NASDAQ Composite Index rose in 
value by over one-thousand percent.
i
  Evidence now suggests that profits for many technology firms 
during this period may have been materially inflated and/or overstated
ii
; however, much of that 
evidence did not come to light until several years after investors had capitalized profits that were, as originally 
reported, well above trend.  A cursory review of these events suggests investors may have been engaged in a rational 
appraisal of intrinsic value for the technology sector based on information available at the time. 
 
 In an effort to rationalize the price gains garnered by technology shares in the 1990s and to gain further 
insight into the ex ante expectations of technology investors during this period, this case study will critically 




framework and employ it to estimate the value of a large proportion of 
the US technology sector as of 1999.  This calculated value can then be compared with the equity market value of 




Economic Value Added (EVA
™
) is a proprietary valuation framework developed by the consulting firm 
Stern Stewart and broadly introduced in G. Bennett Stewart’s book Quest for Value (1991).  EVA™ is a derivative of 
the traditional residual income model (see Bromwich and Walker, 1998) distinguished from the latter principally by 
the accounting adjustments to profits and capital specified by Stern Stewart.  Indeed, Chen and Dodd (1997) note 
that most of the EVA
™
 and residual income variables are highly correlated and nearly identical in terms of the 




 has engendered a great deal of attention from American and European companies, consultants, 
accounting firms, security analysts, fund managers, and the media.  In 1996 for example, Fortune Magazine
iii
  
trumpeted that hundreds of companies had “renounced” earnings per share in favour of EVA™ as a means of 
measuring performance and driving stock prices.  The same article noted investment banks CS First Boston and 
Goldman Sachs had recently trained their research staffs in EVA
™
 analysis and several mutual funds had adopted 
EVA
™
 as a stock selection tool.  
B 
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 Stewart (1991) presents EVA
™
 as an economic model of valuation; a method to calculate the true intrinsic 
value of the firm where investors are concerned about the cash generated over the life of the business and the risk of 
the cash receipts.
iv
  Bromwich and Walker (1998) concur with this assessment, crediting EVA
™
 as “…a measure of 
investment performance which is consistent ex ante with [discounted cash flow] analysis, whilst also providing a 




 is computed by taking the spread between the rate of return on capital r and the cost of capital c* 
and then multiplying by the economic book value of the capital committed to the business.  Thus,  
 
EVA = (r – c*) x capital                              (1) 
 
 
which simplifies to net operating profits (after depreciation and taxes) less a charge for the use of capital: 
 
EVA = NOPAT – (c* x capital)                                           (2) 
 
NOPAT may be calculated from an operating perspective as follows: 
 
NOPAT = Sales – Operating Expenses – Taxes                              (3) 
 
where operating expenses include depreciation, and taxes are only the actual cash operating taxes paid during the 
period. 
 
NOPAT may also be calculated from a financing perspective as follows: 
 
NOPAT =  Income available to Common + Preferred Dividend +            (4) 
 Minority Interest Provision + Interest Expense after Taxes 
 
To eliminate accounting “distortions”12, the EVA™ calculation calls for any increase in equity equivalents, 
unusual losses, and R&D outlays to be added back to income. 
 
Capital is defined as:  
 
Common Equity + Preferred Stock + Minority Interest + All Debt   (5)  
 
where equity equivalents, unusual losses, and R&D outlays are added back to common equity as they were to 
income in the NOPAT calculation. 
 
The cost of capital c* is the weighted average cost of capital to the firm, computed by adding the 
proportionate after-tax cost of debt with the proportionate cost of equity: 
 
c* = [(1 – t)b x D/Capital] + [y x E/Capital]                                    (6) 
 
where t is the marginal corporate income tax rate, b is the firm’s borrowing rate and y is the cost of equity. 
 
Stewart’s (1991) examples for calculating the cost of equity propose the use of the Capital Asset Pricing 
Model (CAPM) for determining equity risk premiums. 
 
Taken together, Stewart’s (1991) “EVA™ Valuation Formula” is: 
 




 is grounded in orthodox financial theory which values the firm as a function of its expected, future 
cash flows and appropriate discount rate.  Although such an economic model offers the promise of a better estimate 
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of corporate value than a pure accounting approach that may fail to consider the time value of money and risk, the 
utility of EVA
™
 rests entirely upon the accuracy of the future cash flow forecasts and calculation of the cost of 
capital. 
 
In a RoundTable discussion of EVA
™
 hosted by Johnson and Johnson in 1994
v





 is subject to the same uncertainties in estimating future cash flows as conventional discounted cash 
flow analysis. This is particularly the case with technology firms where large operating losses early in the product 
life cycle are often followed by a period of competitive advantage of unpredictable duration (see Black, Wright, and 
Bachman, 1998; Moore, Johnson, and Kippola, 1999; Damodaran, 2001).   
 
Computing the correct weighted average cost of capital (WACC) for the EVA
™
 valuation is similarly laden 
with uncertainty.  Stewart (1991) recommends use of the CAPM introduced by Sharpe (1964) to derive the returns 
expected by shareholders, however this single-factor model has been extensively tested and criticised by Douglas 
(1969), French and Fama (1992), and others for failing to fully explain returns on equity.  Moreover, as the greatest 
portion of EVA
™
 will be generated, in the majority of cases, well beyond the current operating period (Stewart, 
1991), valuing the company requires an accurate calculation of the firm’s forward WACC and therefore, its forward 
beta coefficient.  Although betas for portfolios have been found to be stable over extended periods (Levy, 1971; 
Blume, 1971; Tole, 1981), the same is not always true for the betas of individual companies (Sharpe and Cooper, 
1972).  In a critical analysis of their own valuation framework which, like EVA
™,
 requires a capital charge element, 
Black, Wright, and Bachman (1998) concede the difficulty in estimating future betas and point out that accurately 
determining the cost of capital requires the ability to forecast future levels of equity and debt on the balance sheet 




 is subject to criticism for its approach to calculating a company’s capital base, as well.  In the 1994 
RoundTable discussion of EVA
™
 discussed earlier, Stewart acknowledges that in total, there are as many as 164 
different “performance measurement issues” related to a company’s accounting system which must be considered 
with the implementation of EVA
™.
  Several of the most common accounting issues and adjustments include: 
  
 Acquisitions are treated as if they involved cash outlays rather than a pooling of interests 
 Goodwill related to acquisitions is not amortized. 
 Deferred taxes are added back to book equity. 
 R&D expenditures are added back to book equity. 
 
Several researchers have suggested that the large number of equity adjustments incorporated in the Stern 
Stewart system may not be necessary to achieve the level of value-relevance found in the residual income measure 
(see Chen and Dodd, 1997; O’Hanlon and Peasnell, 1998). 
 
Jerold Zimmerman, co-editor of the Journal of Accounting and Economics, argues that capitalization of 
research and development spending under EVA
™
 may lead to investment and valuation errors due to the failure of 
many R&D projects to evolve into cash-generating assets.
 vii
  Yet, Zimmerman simultaneously acknowledges that 
whereas investments in R&D (and other income producing expenditures like advertising) often have future payoffs 
that are not picked up by pure accounting-based measures of value, these will be appropriately reflected in EVA
™. 
 
The Boston Consulting Group (BCG) (1996) suggests that EVA
™
 is distorted in both the early years as well 
as in the later years following a new investment.  The former occurs, according to BCG, when earnings rather than 
total cash flow are credited against book investment, and the latter occurs due to EVA
™’s choice of depreciating 
book investments rather than the original cash investment.  Specifically, BCG points out that the combination of 
subtracting depreciation expense from operating cash flow and subtracting accumulated depreciation from book 
capital may result in EVA
™
 rising as assets depreciate even if product prices and earnings are eroding.   
 
 A critical assumption of the EVA
™
 model is that of perfect capital markets and rational expectations where 
market value added (MVA) is always equal to the present value of all future EVA
™
 (Stewart, 1991).  Under this 
assumption, corporations are always being correctly valued by the stock market based solely on their ability to 
deliver economic profits.  As evidence that financial restructurings are producing or portending gains in economic 
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value, Stewart (1991) cites a number of cases where firms enjoyed immediate and significant gains in their share 
price after announcing or undergoing recapitalizations.  Without the benefit of long-term empirical studies however, 
it is impossible to know 1) if the stock market is bidding up share prices solely in anticipation of higher economic 
profits, and 2) if these restructurings actually contributed to long-term residual income, thus confirming the perfect 
foresight of the stock market.  Without such empirical evidence, it is circular reasoning to argue that stock market 
gains ex ante prove the firm is adding permanent economic value by virtue of a recapitalization. 
 
 Each year, the Journal of Applied Corporate Finance (JACF), published by Stern Stewart, produces a list 
of the 1,000 largest publicly owned US industrial and non-financial service companies ranked by market value 
added (MVA).
viii
  In an article drawn from the JACF, Ross (1998) asserts that MVA has “…increasingly been 
recognized as the best gauge of a company’s success in creating (or destroying) shareholder wealth”.  Ross (1998) 
further argues, “… there is a significant correlation between MVA and EVA™”.  To support this argument, Ross 
(1998) offers a number of anecdotal “success stories” of firms who have implemented the EVA™ management 
program, including Harnishfeger Industries, Equifax, and Manitowoc.  Harnishfeger Industries is reported to have 
been generating negative EVA
™
 prior to the advent of its EVA
™
 program but moves to a position of positive EVA
™
 
within three years following implementation while its stock price more than doubles during the same period.  
Similarly, Equifax reports its EVA
™
 moving from negative $21.5 million to positive $46.1 million in the three years 
following program implementation while its total return to shareholders rises to 55% and 45% in years two and 
three, respectively, following implementation.  Manitowoc calculates its EVA
™
 as increasing from negative $15 
million to positive $10 million and its stock price rising fourfold during the same period. 
 
Notwithstanding the aforementioned anecdotal stories, Ross (1998) offers no formal evidence 
demonstrating a positive association between MVA and EVA
™
.  Indeed, based on tables published by Stern Stewart 
on their web site
ix
, the late 1990s appear to have been a period of marked disparity between contemporaneous levels 
of MVA and EVA
™
 for many US companies, particularly technology firms.  In 1996 for example, Stern Stewart 
reports Cisco had MVA of $38,341 million while EVA
™
 is calculated at a mere 2 percent of this figure or $794 
million.  In the same year, MVA for Intel is reported to be $86,481 million whereas EVA
™
 is just $3,605 million.  
Microsoft, which ranked third amongst all US firms with $89,957 million in MVA for 1996, generated just $1,727 
million in EVA
™.
  Motorola, which enjoyed a positive MVA of $18,758 million in 1996, actually destroyed $630 
million in EVA
™
 for the year.  Comparably wide gaps between EVA
™
 and MVA can be observed in 1997, 1998, 
and 1999 (see Table 1). 
 
 Ross (1998) and Stewart (1991) concede it is difficult to establish a precise relationship between MVA and 
EVA
™
 because market valuations often anticipate future changes in EVA
™.
  This qualification however, only begs 
the question of whether financial markets are rewarding companies for higher EVA
™
 with a higher market value.  If, 
for example, EVA
™
 were to be regressed on MVA on a lagged basis and no positive correlation found, advocates of 
EVA
™
 could always argue that ex ante MVA represented the market’s best estimate of ex post EVA™ which 
ultimately failed to materialize.  In other words, it could be argued that a weak statistical association between MVA 
and EVA
™
 is simply the result of the market’s inability to perfectly forecast future EVA™. 
 
 Damodaran (2001) points out that firms can increase their EVA
™
 from assets in place while simultaneously 
seeing their market value decline under the following circumstances: 
 
1. The increase in EVA™ is the result of a shrinking of the capital invested in the firm.  Restructuring charges 
and stock buybacks for example, can reduce capital invested and make EVA
™
 a much larger figure while 
yielding no gain or a reduction in market value. 
2. The increase in EVA™ from existing assets is generated by sacrificing future investments and the economic 
value that would have been created by those investments. 
 
An illustration of the dilemma facing investigators addressing the question of the relationship between 
MVA and EVA
™
 can be found in Ross’s (1998) discussion on International Multifoods.  Ross indicates that the 
company share price increased from $15 to the “mid-$20s” just after the news release announcing the firm’s 
implementation of the EVA
™
 management system.  For Ross, this is prima facie evidence that investors expect 
EVA
™
 adopters to add to intrinsic value.  Ross reveals however, that concurrent with the EVA
™
 announcement by 
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International Multifoods, analyst reports were issued containing optimistic profit forecasts for the company.  
Clearly, a case can be made that it was these forecasts, rather than the specific adoption of EVA
™,
 that led to the rise 
in market value.   
 
 The Boston Consulting Group (BCG) (1996) argues that EVA
™
 is not strongly correlated with MVA due to 
the latter’s omission of dividend income.  As an alternative (and purportedly more complete) measure of changes in 
shareholder wealth, BCG proposes total shareholder return (TSR), a metric that explicitly includes dividend income 
and is unbiased by market capitalisation.  Holt Value Associates (undated), another consultancy specialising in 
valuation frameworks, endorses TSR, and Price Waterhouse executives Black, Wright, and Bachman (1998) count 
dividends as well as capital appreciation in their shareholder value model (SHV).  It should be noted however, that 
TSR is itself, marked by a low correlation with EVA
™
 (BCG, 1996) due to the distortions introduced by using book 
capital discussed earlier.   
   
2.1 EVA and the Valuation of Technology Firms 
 
 For a variety of reasons to be discussed here, EVA
™
 may serve as a constructive tool when valuing 
technology firms.  In a comparison between EVA
™
 and conventional discounted cash flow analysis, Stewart (1991) 
points out that many fast-growing technology companies will run free cash flow deficits for a number of years as 
they invest heavily in new projects.  Negative free cash flow makes it problematic to value these type of firms with 
DCF in the early business stages, whereas the EVA
™
-prescribed alternative of deducting a capital charge from 
NOPAT for each operating period, and then discounting all future EVA
™
 to arrive at present value, appears to 




 also appears to account for the characteristic asset base of many technology firms.  As discussed 
earlier, Stern Stewart capitalize intangible assets like R&D and some forms of intellectual capital to more accurately 
gauge returns on investment for firms with significant intangible assets.  A number of studies offer empirical support 
for the Stern Stewart approach as they demonstrate a positive association between expenditures normally accounted 
for as expenses, and stock market value.  Ben-Zion (1978) for example, finds that firms’ market values minus book 
values are cross-sectionally correlated with R&D and advertising expenditures.  Similarly, Hirschey and Weygandt 
(1985) demonstrate that Tobin’s Q values are cross-sectionally correlated with R&D to sales ratios.  Lev (1996) 
reports that both annual net investment in R&D and accumulated R&D capital are value-relevant to investors; 
however, estimated R&D capital does not appear to be fully reflected contemporaneously in stock prices.  
Examining internet companies, Hand (2000) finds that market values are increasing and concave in R&D, selling, 
and marketing expenses when net income is negative, although the effect weakens after the first two fiscal quarters 
following the IPO.  In a study of 300 companies listed on the London Stock Exchange, Stern Stewart Europe 
Limited (1999) divides firms into 14 industry and service sectors, further delineating them by EVA
™
-related 
performance.  Their results demonstrate that market values rise when R&D expenditures are increased in certain 
sectors, i.e., electronics and electrical, such that the stronger the current economic performance, the greater the 
positive impact of increases in R&D on both MVA and share prices.  Stern Stewart concludes that where companies 
have a track record of being able to create a defensible competitive advantage, i.e., technology firms, investors will 
reward increases in R&D with higher share prices. 
 
 In their best-selling 1998 book The Gorilla Game, Moore, Johnson, and Kippola rely heavily on the EVA
™
 
framework to rationalize the market values awarded to large technology firms like Cisco, Microsoft, and Intel during 
the 1990s.  These authors suggest that by virtue of their competitive advantage in a new product or sector niche, the 
above firms were able to command a superior spread between returns on capital and their cost of capital 
(Competitive Advantage Gap) over an extended interval (Competitive Advantage Period).  At the same time, intense 
market demand for their products drove these companies to maximize new investment in a quest to maximize 
output.  These factors – a rise in the spread between the return on capital and the cost of capital along with a large 
increase in the capital base – directly contributed to substantially higher EVA™ and consequently, a higher share 
price for market leaders. 
 
 Notwithstanding these endorsements, EVA
™
 does not provide a ready solution to the valuation of 
technology companies.  Capital investment and cash flow growth rates must still be forecast by the appraiser so as to 
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fix the period of competitive advantage during which the firm can be expected to earn a positive spread between 
returns on capital and the cost of capital.  As discussed earlier, this is traditionally difficult to do in the case of 
technology firms.  Further, over optimism associated with the number of companies who can be expected to 
maintain a competitive advantage may bias the estimating process across an entire sector. 
 
 Moore, Johnson, and Kippola (1998) for example, suggest that share prices for technology firms were 
driven primarily by industry “hypergrowth” in the 1990s as consumers and investors rushed to embrace new 
technologies.  Yet, these authors simultaneously acknowledge that only one company in each market segment will 
be perceived by investors as ultimately coming to dominate that segment and receive a value premium therefore, 
that reflects the expectation of large and increasing EVA
™
 over time.  While this notion may have applied to a 
quasi-monopoly like Microsoft, it fails to explain how dozens of technology companies competing within each 
segment could have been awarded the EVA
™
 growth premiums seen in the 1990s. 
 
 Damodaran (2001) underscores another weakness of EVA
™
 as a tool for valuing technology issues when he 
notes that companies who buy back company stock can increase EVA
™
 simply by reducing the amount of capital 
invested in the business.  As a large number of technology firms undertook substantial share repurchases to 
accommodate employee stock option programs during the 1990s
x
, we might expect measures of EVA
™,
 and 
therefore estimated corporate values, to be overstated in many cases. 
 
 Other writers have suggested that EVA
™
 is ultimately limited in its ability to capture the value of 
knowledge-intensive firms like those in the technology sector.  Equipped with empirical “stories” drawn from 
industry, Mouritsen (1998) argues that whereas EVA
™
 is framed around a calculation of value based upon risk 
assessment and quantities taken from financial statements, intellectual capital is a more qualitative endeavour which 
resists measurement.  For Mouritsen, “…people rather than things are decisive growth drivers” and “…growth is the 
outcome of skilfully managing the relationship between tangible and intangible assets”. 
  
Mouritsen’s criticisms of EVA™ may be overstated.  While it is true that EVA™ seeks to measure value in 
terms of economic profits, the Stern Stewart framework explicitly or implicitly accounts for many of the intangible 
assets owned by the firm, the goodwill of customers, and the knowledge and competence of its employees from 




In an effort to rationalize the price gains garnered by technology shares during the stock market boom of 
the late 1990s, and to gain further insight into the ex ante expectations of technology investors during this period, 
one can employ EVA
™
 to estimate the value of a large segment of the US technology sector as of 1999.  This 
calculated value can then be compared with the equity market value of the sector at the time. 
 
The data sample reflects three discrete industrial segments within the technology sector.  1999 calendar-
year financial information for each industry is drawn from the Value Line database which aggregates and reports 
accounting data for large public firms in 110 industries.  Research and development expenditures for the same 
industries are drawn from the National Science Foundation’s primary sourcebook: Research and Development in 
Industry: 1999
xi
 which surveys public and private companies annually for their R&D expenditures.  As the Value 
Line database addresses itself primarily to large, publicly-traded firms, companies with R&D programs of less than 
$10 million are eliminated from the composite sample.  This filter also enables the analyst to more closely match the 
total number of companies within each industry reported by the two data sources. 
 
Table 1: EVA™ and MVA for Large Technology Firms (in millions $) 
Firm 1997 EVA™ 1997 MVA 1998 EVA™ 1998 MVA 1999 EVA™ 1999 MVA 
Cisco 794 38,341 1,472 50,422 1,849 135,650 
Intel 3,605 86,481 4,821 90,010 4,280 166,902 
IBM (2,743) 22,944 (1,561) 49,101 (1,058) 116,572 
Microsoft 1,727 89,957 2,781 143,740 3,776 328,257 
Motorola (630) 18,758 (742) 14,045 (2,830) 17,254 
  Source: Stern Stewart & Co. 
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Table 2: EVA Inputs 




 for each industry can be computed as per equations 1- 7 above with equity values substituted 
for capital values, e.g., return on equity rather than return on capital.  As discussed earlier, there are as many as 164 
different accounting issues and adjustments made by Stern Stewart in their calculation of EVA
™
 many of which are 
not publicly disclosed and cannot therefore, be performed in the exercise presented here.  One can however, add 
estimated annual R&D expenditures, less a charge for amortization or depreciation, to aggregate NOPAT and to the 
aggregate book value of equity for each industrial sector.  Consistent with IRS rules, aggregate R&D expenditures 
have been added back to these accounts less depreciation of 10 percent reflecting a 10-year ratable schedule.  Cost 
of equity is calculated using the CAPM with a risk-free rate equal to the average constant maturity rate for 10-year 
US Treasury bonds in 1999 (5.30 percent), a long-term historical risk premium for the stock market of 4.75 
percent
xii
, and measured average beta for each sector drawn from the Value Line database.  As many influential 
analysts and economists in the late 1990s had forecast earnings for technology firms to grow by an average 25 
percent per year in the immediately subsequent ten year period
xiii
, annual increases in NOPAT of 25 percent are 
projected extending out to 2009.  Beyond 2009, sectors are assumed to generate returns on equity equal to their cost 
of equity and thus, no new EVA is created.  All EVA
™ 
inputs for base year 1999 are provided in Table 2. 
 
4 RESULTS/SOLUTION  
 
Results for the EVA
™
 valuations are presented in Tables 3 - 5.  As can be seen, notwithstanding the 
adjusted recovery of research and development expenditures and the assumption of enormous compound growth in 
net operating profits, calculated equity values for each industry based on EVA
™
 are significantly less than 
concurrent market values for the same.  Shareholders awarded the Semiconductor and Semiconductor Capital 
Equipment industry a market value nearly double that of its intrinsic value.  The market value for the Computer 
Software and Services segment was over 144 percent of its EVA
™
  calculated value and the Computers and 









5 DISCUSSION AND CONCLUSION 
 
This case study critically examines the Economic Value Added (EVA
™
) framework and employs EVA
™
 to 
estimate the intrinsic value of a large proportion of the US technology sector as of 1999.  The results underscore data 
published by Stern Stewart on their website, which depicts a marked disparity between contemporaneous levels of 
MVA and EVA
™
 for technology firms in the late 1990s (see Table 1).  Stewart (1991) suggests that such gaps may 
simply reflect market expectations of increasing EVA
™
 over time; however, the assumptions built into the model 
presented here; i.e., 25 percent annual increases in NOPAT over a ten-year period, accompanied by substantial 
spreads between returns on equity and the cost of equity, amply allow for this prospect. 
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Thus, one is left with the question of how to bridge an immense divide between calculated intrinsic values 
for the technology sector and concurrent market values for the same.  It is possible, of course, that the gap observed 
is a result of limitations in our application of EVA
™
 – the inability, for example, to issue all of the accounting 
adjustments prescribed by Stern Stewart.  As noted earlier, however, several researchers report that these 
adjustments are not necessary to achieve the level of value-relevance found in the standard residual income measure 
(see Chen and Dodd, 1997; O’Hanlon and Peasnell, 1998).   
 
Alternatively, it may be, as Biddle, Bowen, and Wallace (1996) find, that earnings are more strongly 
associated with market values than is EVA
™
.  Both contemporaneous and forecast earnings growth for large 
technology firms were well above historical norms when share prices were rising strongly in the late 1990s.  This 
might support record MVA.  Yet Shiller (2000) points out that earnings growth on a similar scale had occurred 
several times prior to the 1990s with no comparable boom in equity prices.  Moreover, in January of 2000, a point 
when technology shares constituted over 30 percent of the S&P 500 Index (contributing substantially to the overall 
value of the Index), the price-earnings ratio for the S&P 500 hit a record high of 44.3
xiv
 reflecting a similarly wide 
gap between earnings and market values to that of EVA
™ 
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